The MS group of patients had significantly higher BMI, waist circumference, systolic and diastolic blood pressure, triacylglycerol levels, fasting glucose and insulin, HOMA, and uric acid levels than the control group (P < 0.0001). This evidence concerns the gene INS and myeloid sarcoma.